Clinical Trials Directory

Trials / Completed

CompletedNCT03222037

Evaluation of Electronic LogMar Visual Acuity and Contrast Sensitivity in a Population of Contact Lens Wearers

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
49 (actual)
Sponsor
Johnson & Johnson Vision Care, Inc. · Industry
Sex
All
Age
18 Years – 35 Years
Healthy volunteers
Accepted

Summary

This is a bilateral, non-dispensing, randomized, cross-over, single-masked study. There are a total of 3 visits where all study endpoints will be measured in all subjects at baseline with habitual lenses and under the two testing treatments sequentially in separate visits based on the randomization scheme

Conditions

Interventions

TypeNameDescription
DEVICEsenofilcon AAcuvue Oasys 1-Day
DEVICEControlTrial Frame with best spherocylindrical refraction (SCR)

Timeline

Start date
2017-06-27
Primary completion
2017-08-04
Completion
2017-08-04
First posted
2017-07-19
Last updated
2019-09-10
Results posted
2018-08-24

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03222037. Inclusion in this directory is not an endorsement.

Evaluation of Electronic LogMar Visual Acuity and Contrast Sensitivity in a Population of Contact Lens Wearers (NCT03222037) · Clinical Trials Directory